Founders Morris Goodman


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 6
Average round size
The average size of a deal this fund participated in
Portfolio companies 5
Rounds per year 0.15
Lead investments 1
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 1
Key employees Soon

Areas of investment

  • Pharmaceutical
  • Biotechnology
  • Clinical Trials
  • Communities
  • Manufacturing

Pharmascience appeared to be the Corporate Investor, which was created in 1983. The main department of described Corporate Investor is located in the Montru00e9al. The company was established in North America in Canada.

The fund has exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. Among the most popular fund investment industries, there are Medical, Life Science. Among the most popular portfolio startups of the fund, we may highlight Edesa Biotech, RDD Pharma.

Opposing the other organizations, this Pharmascience works on 4 percentage points more the average amount of lead investments. The top amount of exits for fund were in 2019. The fund is constantly included in less than 2 deals per year. Considering the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top activity for fund was in 2017.

The usual cause for the fund is to invest in rounds with 2-3 partakers. The meaningful sponsors for the fund in investment in the same round are Signet Healthcare Partners, OrbiMed, Lumira Ventures.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Pharmascience:
Typical Co-investors
Pharmascience is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Pharmascience:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
BaseCamp Ventures Moorestown, New Jersey, United States
Calculus Capital England, London, United Kingdom
Ferguson Ventures Newport News, United States, Virginia
GS Group Russian Federation, Saint Petersburg, Saint Petersburg Oblast
ICD-PS Jeddah, Makkah, Saudi Arabia
Nanjing Zhongyiren Investment China, Jiangsu, Nanjing
What If Ventures Frisco, Texas, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

RDD Pharma

$9M16 Nov 2017 Israel, North District, Israel

Edesa Biotech

Life Science
$7M20 Sep 2017 Markham, Ontario, Canada

Pharmaceutics International

Clinical Trials
$93M06 Sep 2016 Hunt Valley, Maryland, United States

Health Care
$30M09 Feb 2015 New Jersey, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Pharmascience?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: